文献速递儿童青少年精神

脐带血循环microRNA预测注意缺陷多动障碍诊断

Circulating MicroRNAs in Cord Blood to Predict Attention-Deficit/Hyperactivity Disorder Diagnosis.
PubMed 文献 · Biol Psychiatry · 2025-10-17

研究基于挪威MoBa队列,纳入206名ADHD儿童、207名对照及其父母,检测出生时脐带血血浆51种microRNA表达。7种microRNA在ADHD与对照间差异表达,31种与8岁父母评定ADHD症状分呈线性关系;19-microRNA预测模型在测试人群中AUC为0.959、准确率0.893。

要点

  • 出生时脐带血7种microRNA与ADHD诊断差异表达,31种与8岁症状分线性相关。
  • 19-microRNA预测模型区分ADHD诊断AUC=0.959、准确率=0.893。
  • 预测集涉及多巴胺能突触、昼夜节律和轴突导向等通路。

核心结论

  • 出生时循环microRNA表达水平可能用于预测ADHD诊断风险。
  • 19-microRNA组合应纳入未来生物标志物面板开发。

研究设计与样本

  • 研究人群为MoBa队列中206名ADHD儿童(33.0%女性)、207名对照儿童(33.8%女性)及其父母。
  • 采用定量聚合酶链反应检测出生时脐带血血浆及父母早孕期血浆中51种选定microRNA的表达水平。

主要发现

  • 31种microRNA与8岁时父母评定的ADHD症状分呈统计学显著线性关系。
  • 19-microRNA ADHD预测模型在测试人群中区分度良好(受试者工作特征曲线下面积=0.959,准确率=0.893)。
  • 对19-microRNA预测集的功能分析显示其涉及多巴胺能突触、昼夜节律和轴突导向等高相关通路。
  • 父母microRNA表达水平与儿童ADHD诊断和/或ADHD症状分显著相关。

关键数值与推荐

  • 19-microRNA预测模型在测试人群的受试者工作特征曲线下面积=0.959,准确率=0.893。

临床怎么用

  • 提示出生时脐带血microRNA可作为ADHD风险预测的候选生物标志物。
  • 19-microRNA组合值得在未來生物标志物面板开发中进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There are large knowledge gaps in the etiology of attention-deficit/hyperactivity disorder (ADHD), and although it is a prevalent and highly heritable neurodevelopmental disorder, diagnosis can be challenging. We aimed to assess the association of circulating blood plasma microRNAs (miRNAs) at birth with ADHD for use as biomarker candidates and build an miRNA-based prediction model. METHODS: Our study population consisted of 206 children with ADHD (33.0% female), 207 control children (33.8% female), and their parents from the MoBa (Norwegian Mother, Father, and Child Cohort Study). Expression levels of 51 selected miRNAs in plasma from children's cord blood at birth and from both parents during early pregnancy were quantified by quantitative polymerase chain reaction and tested for association with children's ADHD diagnosis and ADHD symptom scores based on ratings by parents. RESULTS: Seven miRNAs were differentially expressed at birth in children with ADHD and control children (false discovery rate < .05), and 31 had a statistically significant linear relationship with parent-rated ADHD symptom score at 8 years. A 19-miRNA ADHD prediction model achieved good discrimination in the test population (area under the receiver operating curve = 0.959, accuracy = 0.893). Functional analysis for the 19-miRNA prediction set revealed involvement in several highly relevant pathways, e.g., dopaminergic synapse, circadian rhythm, and axon guidance. We also found that parental miRNA expression levels significantly associated with children's ADHD diagnoses and/or ADHD symptoms scores. CONCLUSIONS: We showed that expression levels of circulating miRNAs at birth may be used to predict increased risk of ADHD diagnosis, and our 19-miRNA set should be included in future efforts to develop a biomarker panel.

来源:Biol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Dypås LB, Olsen AK, Gützkow KB, et al. Circulating MicroRNAs in Cord Blood to Predict Attention-Deficit/Hyperactivity Disorder Diagnosis. Biol Psychiatry. 2025. PMID: 41110746. doi:10.1016/j.biopsych.2025.10.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。